| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 | IFEN GmbH IFEN GmbH, a Bavarian based company, provides innovative and leading edge GNSS testing products for the satellite navigation market, for example • GNSS Simulators • RF Signal generators • Test Receivers • GPS, QZSS, SBAS, GALILEO Signal Simulation • navigation test environments • and many more. IFEN, founded in 1998, was starting up with service contracts on EGNOS development, later also on Galileo. The scope of activities for service contracts covers GNSS system studies and analysis, development of algorithms, software and facilities, even up to turnkey systems like the Galileo test range GATE. Service contracts in all fields of GNSS … | 0 | 0 | 0 | 16 |
 |  Green Spot Technologies Challenging the food waste paradigm to feed a better future ✨Earthshot Prize ✨French Tech Agri20 ✨French Tech 2030 Green Spot Technologies (GST) is leveraging solid state fermentation and upcycling to reinvent food ingredient solutions. 1/ Ferment'Up cocoa ingredients alternative solution range of powders for reducing cost and environmental footprint at once 2/ Ferment'Up tomato to sauce manufacturer for decreasing cost and optimising texture in their recipe with 100% of the tomato The company was initially founded in New Zealand following the PhD thesis of Dr. Ninna Granucci. In 2018, after a successful fundraising round, the company relocated to France, where … Tags: FrenchTech2030 Type: | 42 | 11 | 39 | 19 |
 | XenTech Premium quality preclinical oncology CRO, pioneering the PDX technology for more than 16 years. XenTech is Biotech/Contract Research Organization (CRO) dedicated to translational research in oncology which offers preclinical services to evaluate the anti-cancer potential of drug candidates (PDX, CDX,...) In addition, XenTech develops internal R&D programs to correlate drug response with molecular features of tumors and identify cancer biomarkers and therapeutic targets. patient-derived tumor xenograft models, oncology, biomarkers, efficacy preclinical studies, PDX, CDX, in vivo, and in-vitro assays Type: | 4 | 2 | 4 | 37 |
 | omicX Unleashing the value of big biodata omicX is a global benchmark in big biodata analytics. Powered by machine teaching, its unique dynamic analytics ecosystem deciphers and analyses life science data. Combining artificial and collective intelligence, omicX’s disruptive approach empowers life science practitioners to shorten and improve decision-making, in order to accelerate scientific breakthroughs and go to market strategies. Accessible via web app, omicX is recognized as the most insightful life science analytics platform by a community of more than one million high-level users every year. Bioinformatics, Computational biology, Biologial data analysis , and Big data Type: | 0 | 0 | 0 | 0 |
 | EcoMundo Our expertise, your global compliance Your go-to for regulatory guidance, excelling in global compliance and product stewardship. For over 2 decades, we've innovated to support a diverse clientele, from manufacturers to end users. Our arsenal? Cutting-edge software solutions and in-depth regulatory consulting. Dive into our database of global environmental regulations and steer through compliance complexities. Why EcoMundo? Because we're more than a service; we're a partner. With strong ties to regulatory authorities and a commitment to staying ahead of changes, we ensure you're always compliant, always competitive. Choose EcoMundo. Choose excellence, innovation, and a future-proof regulatory strategy. Environmental Services, Software … Type: | 6 | 2 | 6 | 172 |
 | EikoSim Bridge the gap between test and simulation EikoSim is committed to help simulation teams to bridge the gap between test and model during the development phase in mechanical industries. EikoTwin users respond faster to program requests and reduce delivery time to the final customer. digital image correlation, validation, finite element analysis, identification, mechanics, testing, simulation, and VVUQ | 17 | 4 | 13 | 9 |
 | Syndivia Syndivia is committed to enhancing treatment options for cancer patients with solid tumors by leveraging the distinctive properties of targeted DAR1 antibody-drug conjugates, which offer improved tumor penetration, stability, and efficacy. Drug development, Biotechnology, Pharmaceuticals, Antibody-drug conjugates, DAR1 ADC, and ADC Type: | 5 | 3 | 0 | 5 |
 | Elveflow Microfluidics | an Elvesys brand Microfluidic premium instrumentation & solutions for all 👉 https://www.elveflow.com World leader in premium microfluidic instrumentation. Proven track record delivering systems for the best institutions worlwide. Elvesys captures the spark of smart ideas to give life to innovative concepts that will iIlluminate the world. We stand for innovation, quality, performance, fun and a sense of competitive challenge. Elvesys was built on a strong entrepreneurial spirit and founded on the belief that microfluidics will change the world. This is why in the recent years, Elvesys has spawned a number of innovative companies from microfluidics innovations: -Elveflow: Elveflow focuses on the development of … Type: | 14 | 2 | 11 | 32 |
 | PrimaDiag SAS The easiest way to automation PrimaDiag, a French company, based at Biocitech (dedicated to Science and biotechnologies) park in the Paris area, develops compact robotics platforms for rapid automation of a large variety of biology protocols and in particular for molecular biology protocols. PrimaDiag began as an engineering consulting firm in October, 2007 and acquired expertise in the domains of robotics, computer science and biology through various projects realized in France and in Europe. In 2014, with its acquired experience, PrimaDiag launched its new range of ” ACSIA “ products offering turnkey solutions, based on a new concept, for the … Type: | 5 | 2 | 3 | 6 |
 | Stilla Technologies Discover the Sensitivity & Simplicity of Multiplex Crystal Digital PCRTM Stilla Technologies is a leading global biotechnology company that focuses on accelerating development of next-generation genetic testing by providing researchers and clinicians with a flexible Digital PCR solution for high-resolution genetic analysis and assay development. Stilla’s next-generation Multiplex Crystal Digital PCRTM technology employs cutting-edge microfluidic innovations and integrates the entire dPCR process on a single chip. The naica® system is highly sensitive, fast, and features an easy workflow, higher levels of multiplexing, and intuitive software. Stilla developed the world's first 6-color Digital PCR Platform, providing High Multiplexing and Sensitivity for … Type: | 11 | 5 | 7 | 100 |
 |  Abtech Therapeutics Expertise in protein engineering | in silico & in vitro antibody discovery platform We work in partnership with technology platforms, pharmaceutical companies, and academic research groups to create next generation cell and molecular therapies. We integrate novel technologies into a synthetic antibody platform to provide the most advanced discovery engine possible. Type: | 2 | 2 | 0 | 2 |
 | The RSA (The royal society for arts, manufactures and commerce) We unite people and ideas in collective action to create opportunities to regenerate our world. We are the RSA. The royal society for arts, manufactures and commerce. We unite people and ideas in collective action to create opportunities to regenerate our world. The RSA is registered as a charity in England and Wales no. 212424 and in Scotland no. SC037784 The RSA is registered as a charity in England and Wales no. 212424 and in Scotland no. SC037784 Type: | 56 | 18 | 19 | 2,035 |
 | Eurofins Viracor Get results faster, when it matters most. It’s so much more than a specimen. It's a life. With over 30 years of specialized expertise in infectious disease, immunology, transplant, and allergy testing for immunocompromised and critical patients, Eurofins Viracor is committed to helping medical professionals, transplant teams, reference labs and biopharmaceutical companies get results faster, when it matters most. Eurofins Viracor is passionate about providing timely, actionable test results, never losing sight of the connection between the testing we perform and the patients our results ultimately serve. Find out more by visiting us at www.eurofins-viracor.com/clinical Eurofins Viracor is an equal … Type: | 1 | 1 | 0 | 268 |
 | Eurofins Genomics The DNA Universe Eurofins Genomics was founded in 1990 and is part of the Eurofins Scientific Group, a Life Science Company with laboratories in 61 countries and 61,000 employees. We are an international provider of genomic services around the core business lines next generation sequencing, genotyping, gene expression, custom DNA sequencing, oligonucleotides, siRNA and gene synthesis. Our services are tailored for pharma, diagnostics, agriculture, food, biotechnology and research applications worldwide. Imprint: https://www.eurofinsgenomics.eu/imprint/ Privacy Note: https://www.eurofinsgenomics.eu/privacy/ Next Generation Sequencing, Custom DNA Sequencing, Oligonucleotides, Molecular Biology, Gene Synthesis, Genotyping, and Gene Expression | 1 | 1 | 0 | 334 |
 | Bumble Bee Foods The Bumble Bee Seafood Company is on a mission to create a new generation of seafood lovers. The Bumble Bee Seafood Company is passionately pursuing its purpose of feeding people’s lives through the power of the ocean. The iconic 120-year-old fishing company consistently aims to deliver delicious, healthy and affordable food to consumers while working hard to find new ways to protect the ocean and those that rely on it. Bumble Bee is firmly anchored in a commitment to connect the world to the ocean by re-defining sourcing, producing and enjoying products from and inspired by the ocean. Bumble Bee’s … Type: | 7 | 2 | 2 | 303 |
 | miRecule, Inc. RNA Therapeutics We develop first-in-class RNA-based therapies, with lead programs in Head & Neck Squamous Cell Carcinoma (HNSCC) and Facioscalpulohumeral Muscular Dystrophy (FSHD). Our approach to drug design revolves around using genomic patient data to create highly tailored therapeutics – the right drug for the right patient. Our proprietary DREAmiRTM platform utilizes genomic and outcome data from thousands of patients to identify underlying genetic changes that cause their disease, and then creates a novel RNA therapeutic that can directly target and fix that genetic abnormality. Type: | 2 | 2 | 1 | 19 |
 | Fundación Pasqual Maragall Por un futuro sin Alzheimer / A future without Alzheimer's At the Pasqual Maragall Foundation we are working towards a future without Alzheimer’s. Our research focuses on how to stop this disease and prevent its progress before the onset of symptoms, given that any damage it causes in the brain begins decades before the disease manifests itself. We also help to improve the lives of people with the disease and their families by offering therapy groups for caregivers. The Foundation also works to raise the public’s awareness on the effects and consequences of Alzheimer’s and to obtain support for scientific … Type: | 17 | 3 | 9 | 190 |
 | bioRN Life Science Cluster One of Germany’s strongest biotech hubs, fostering health innovations and creating a rich translational ecosystem! BioRN is a life science research and industry cluster dedicated to the development of cell-specific, molecular and personalised innovative treatments. The BioRN Cluster stands for the development, networking, representation and promotion of the life science region into one of the leading life science clusters in Europe. The cluster-members include renowned academic research institutions such as the Universities of Heidelberg, the German Cancer Research Center (DKFZ) and the European Molecular Biology Laboratory (EMBL) and global health care companies such as AbbVie, Boehringer Ingelheim, Johnson & Johnson, … Type: | 29 | 8 | 29 | 12 |
 | Institute of Molecular Biology and Biotechnology (IMBB) The Institute of Molecular Biology and Biotechnology (IMBB) is based in Heraklion (Crete), and is conducting basic and applied research in established and emerging areas of Biomedical science. IMBB was founded in 1983 and is part of the Foundation for Research and Technology-Hellas (FORTH), one of the largest research centers in Greece. Research at IMBB is diverse and falls into the following areas: Gene Regulation, Developmental Genetics, Neurosciences, Host-Pathogen Interactions and Immunity, Protein Function and Structural Biology. Our multidisciplinary research is supported by state-of-the-art experimental facilities and is enhanced by extensive collaborations and interactions with the other co-located Institutes of … Type: | 3 | 3 | 0 | 188 |
 | International Rice Research Institute IRRI works toward #zerohunger, improved #health and #welfare of #farmers, and #sustainable future through #RiceResearch. Established in 1960, IRRI is among the largest non-profit agricultural research centers in Asia, with headquarters in the Philippines and offices in 14 other nations. We are supported by donors and partners around the globe. Our mission is to reduce poverty and hunger, improve the health of rice farmers and consumers, and ensure that rice production is environmentally sustainable. Follow us on Facebook (facebook.com/IRRI.ricenews), Twitter (twitter.com/irri), and Instagram (instagram.com/irri) for the latest updates and innovations on rice. rice research, capacity building, international development, plant breeding, … Type: | 14 | 4 | 8 | 1,836 |
 | C3 Collaborating for Health Together, we can make it easier to live healthy lives. C3 Collaborating for Health (C3) is a London-based charity with a global focus that counters the chronic non-communicable disease (NCD) epidemic by focusing on the main risk factors. The four big chronic diseases are cardiovascular disease, diabetes, many cancers and chronic lung disease. C3 does this by bringing together different communities to create changes that make it easier for people to: - improve what they eat and drink, - stop using tobacco, and - do more physical activity. C3’s vision is for a world where people are not dying from … Type: | 9 | 2 | 7 | 22 |
 | Lif - Lægemiddelindustriforeningen The Danish Association of the Pharmaceutical Industry. Den danske brancheorganisation for lægemiddelindustrien. Lif is the Danish Association of the Pharmaceutical Industry. Our member companies are behind the majority of the industrial medical research carried out in Denmark. Lif works for the pharmaceutical industry to be perceived as a responsible partner that makes a valuable contribution to society. Lif's mission is to work to ensure that the pharmaceutical industry has the best possible conditions to research, develop, market, distribute and provide information on medicinal products so as to ensure that patients have extensive and rapid access to the best medical treatment. Type: | 6 | 0 | 6 | 46 |
 | Clinton Health Access Initiative, Inc. A global health organization committed to saving lives, reducing the burden of disease and strengthening health systems. CHAI's mission is to save lives and improve health outcomes in low- and middle-income countries by enabling the government and private sector to strengthen and sustain quality health systems. Today, CHAI operates in 36 countries across the world and more than 80 countries have access to CHAI-negotiated price reductions, vaccines, medical devices, and diagnostics. Current programs at CHAI include HIV/AIDS, Malaria, Tuberculosis, Hepatitis, Maternal, Newborn and Reproductive Health, Diarrhea and Pneumonia, Nutrition, Vaccines, Health Financing, Health Workforce, and Cancer. CHAI also has a … Type: | 24 | 7 | 15 | 2,038 |
 | hollandbio Biotech makes life better The mission of hollandbio, the Dutch biotech industry association, is to maximize the contribution of biotech innovations to our society’s health and sustainability. We represent, support and connect an active, privately funded, and rapidly growing community of more than 280 member companies. Our members are a reflection of the biotech sector: from start-ups and SMEs to large companies and multinationals, active in fields ranging from healthcare and agri-food to biobased applications and cultured meat. By tackling the obstacles that hinder our frontrunners, hollandbio aims for progress - even when that means challenging the status quo. Advocacy, … Type: | 23 | 5 | 12 | 24 |
 | BioCanRx Canada's Immunotherapy Network BioCanRx is Canada's immunotherapy network. Our vision is to turn all cancers into curable diseases. We invest in leading edge immune oncology research translating world-class technologies from the lab into early phase clinical trials. BioCanRx provides researchers with access to funding, expertise, training and biomanufacturing facilities and is a leader in the translation, manufacture and adoption of cancer immunotherapies. Type: | 9 | 0 | 9 | 18 |
 | CQDM Facilitateur d'innovation biopharma // Facilitator of biopharma innovation Facilitator of biopharma innovation // Facilitateur d'innovation biopharma. CQDM is a pharma-based consortium active in biopharmaceutical research. Our mission is to support and facilitate multi-stakeholder collaborative R&D aimed at accelerating the translation of innovative technologies into solutions that address unmet medical needs, while generating significant benefits for the Quebec and Canadian economy. CQDM receives financial support from pharmaceutical companies Amgen, AstraZeneca, GSK, Merck, Pfizer, Roche, Sanofi, Servier, Takeda as well as from Quebec’s Ministère de l'Économie, l'Innovation et de l'Énergie (MEIE). For more information: www.cqdm.org. Le CQDM est un consortium pharmaceutique actif … Type: | 15 | 4 | 12 | 33 |
 | Human Technopole The new Italian research institute for Life Sciences based at the heart of MIND - Milano Innovation District. Human Technopole is Italy's new research institute for Life Sciences, based at the heart of MIND in Milan. Our mission is to improve human life & technology. To accomplish its mission, HT’s research strives to unravel fundamental mechanisms relevant to human physiology and disease using a multi-scale systems biology approach, based on a combination of experimental research and theory, coupled with computational biology and Artificial Intelligence. Genomics, Proteomics, Metabolomics, Metagenomics, Imaging, DataScience, Bioinformatics, Immunology, Cancer, Neurobiology, Neurodegeneration, Nutrition, Agriculture, Food, Nanomaterials, Nanotechnology, … Type: | 12 | 2 | 9 | 425 |
 | The Henry M. Jackson Foundation for the Advancement of Military Medicine We advance military medicine for the benefit of soldier and civilian health. #WeAreHJF #milmed #medicalresearch The Henry M. Jackson Foundation for the Advancement of Military Medicine is a global nonprofit organization created by Congress in 1983 to assist in accelerating the progress of military medicine. Our unmatched experience in military medical research makes us uniquely qualified to assist investigators and clinicians in managing scientific research. By providing exceptional program management services, we relieve the administrative burden associated with medical research, empowering researchers to make the medical discoveries our warfighters need. Our mission is to advance Military Medicine and our objectives … Type: | 8 | 1 | 7 | 1,939 |
 | Global Colon Cancer Association The Global Colon Cancer Association is the voice for the millions of colon cancer (CRC) patients worldwide. We advocate for patient centered policy around the globe to ensure increased awareness and screening, access to quality medical treatments and help our member organizations collaborate, innovate and leverage the full potential of effectuating change. The GCCA also supports the creation of new patient advocacy groups in developing areas which have no CRC organizations. The GCCA unites all stakeholders in the battle against this disease with one unified voice. To learn more about Biomarkers, please visit : https://gcca.info/_Linkedin_ The Global Colon Cancer Association … Type: | 9 | 2 | 8 | 7 |
 | New York Genome Center The New York Genome Center (NYGC) is an independent, nonprofit academic research institution focused on furthering genomic research that leads to scientific advances and new insights and therapies for patients with neurodegenerative disease, neuropsychiatric disease, and cancer. Leveraging our strengths in whole genome sequencing, genomic analysis, and development of genomic tools, the NYGC serves as a nexus for collaboration in genomic research for the New York community and beyond. sequencing, bioinformatics, genomics, translational research, big data, data management, integrated genomics, high performance computing, and data storage Type: | 14 | 3 | 11 | 287 |
 | Global Health Technologies Coalition (GHTC) Advancing innovation to save lives The Global Health Technologies Coalition (GHTC) works to save and improve lives by encouraging the research and development (R&D) of essential health technologies. We are a coalition of more than 40 nonprofit organizations advancing policies to accelerate the creation of new drugs, vaccines, diagnostics, and other health tools that bring healthy lives within reach for all people. Type: | 13 | 2 | 12 | 15 |
 | Debbie's Dream Foundation: Curing Stomach Cancer Raising Awareness. Funding Research. Supporting Patients. Achieving the DREAM! Debbie's Dream Foundation: Curing Stomach Cancer is a 501(c)(3) non-profit organization dedicated to raising awareness about stomach cancer, advancing funding for research, and providing education and support internationally to patients, families, and caregivers. DDF seeks as its ultimate goal to make the cure for stomach cancer a reality. Awareness, Advocacy, Research, Support Patient, Families and Caregiver, Stomach Cancer, Gastric Cancer, Stomach Cancer Awareness, Stomach Cancer Advocacy, Stomach Cancer Resarch, Gastric Cancer Awareness, Support Groups, Educational Webinars, Educational Symposia, and Survivor Stories Type: | 3 | 3 | 3 | 15 |
 | Stupid Cancer We make adolescent and young adult cancer suck less. Stupid Cancer a 501(c)3 nonprofit organization, is the leader in young adult cancer advocacy, research, and support. We create shared experiences by producing life-changing live events and digital content that end isolation, build community, provide education, and foster meaningful relationships that last a lifetime. Our mission is to empower everyone affected by adolescent and young adult (AYA) cancer by ending isolation and building community. Our vision is that everyone in the AYA community is supported, understood, and accepted Health2.0, Social Media, Cancer Survivorship, and Youth Culture Type: | 12 | 6 | 7 | 27 |
 | Melanoma Research Alliance The largest non-profit funder of melanoma research worldwide. The Melanoma Research Alliance (MRA) is the largest private funder of melanoma research. Since its founding in 2007, MRA has committed $143 million in funding to advance our understanding of this disease. MRA funds projects in the areas of prevention, diagnosis, and treatment, with the majority of funding allocated for melanoma treatment. Due to the ongoing support of our founders, 100% of every donation to MRA supports melanoma research. The mission of the Melanoma Research Alliance is to accelerate the pace of scientific discovery and its translation into effective options for patients … Type: | 15 | 1 | 15 | 26 |
 | Experimental Cancer Medicine Centres Network (ECMC) First in human. First in class. The ECMC is a truly collaborative, internationally competitive national network of early phase experimental cancer medicine centres, translating the most promising innovations from the academic and industry sectors into the cancer medicines of tomorrow. Experimental Cancer Medicine Centres (ECMC) researchers are world-leading scientists and clinicians who drive the discovery, development and testing of new treatments to combat cancer. The funding supports over 200 staff involved in early phase trials and translational research. The ECMC network is uniquely placed to help industry develop the cancer drugs of the future, bringing together an unrivalled team of … Type: | 4 | 0 | 4 | 10 |
 | Innovative Genomics Institute Advancing genome research for a better world The Innovative Genomics Institute (IGI) is composed of diverse researchers with a powerful combined expertise. After the development of the CRISPR-Cas9 system for rewriting DNA, we saw the potential of applying this technology to solve some of humanity’s greatest problems. Our scientists conduct world-class research, driven by the real possibility to cure human disease, end hunger, and protect the environment. In addition to our scientific efforts, the IGI is committed to advancing public understanding of genome engineering and providing resources for the broader community. Genome Editing, Genetic Engineering, CRISPR, Agriculture, Biomedicine, and Microbiology Type: | 6 | 3 | 4 | 199 |
 | Dana-Farber Cancer Institute Dana-Farber Cancer Institute is committed to providing expert, compassionate care to children and adults with cancer, while advancing the understanding, treatment, cure, and prevention of cancer and related diseases. Cancer research, Adult cancer treatment, AIDS research, Pediatric cancer treatment, Innovation, Research, Patient Services, and Technology Type: | 55 | 16 | 39 | 8,169 |
 | Society for Immunotherapy of Cancer (SITC) SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere. The Society for Immunotherapy of Cancer (SITC) is the world’s leading member-driven organization specifically dedicated to improving cancer patient outcomes by advancing the science and application of cancer immunotherapy. sitc_log_color.png Established in 1984, SITC, a 501(c)(3) not-for-profit organization, serves scientists, clinicians, academicians, patients, patient advocates, government representatives and industry leaders from around the world. Through educational programs that foster scientific exchange and collaboration, SITC aims to one day make the word “cure” a reality for cancer patients everywhere. Currently, SITC … Type: | 12 | 5 | 9 | 61 |
 | Lieber Institute for Brain Development Translating genetic insights into next generation treatments for brain disorders. The mission of the Lieber Institute for Brain Development (LIBD) Maltz Research Laboratories is to discover the genetic and molecular foundations of brain disorders and develop next generation treatments that enhance the lives of those affected my mental illness. The Lieber Institute was conceived from the realization that a new approach is needed to fully exploit the unprecedented opportunities to accomplish the critical goal of helping affected individuals and their families. LIBD aims to transform the research landscape in two ways: by providing new tools for scientific discovery and by … Type: | 2 | 0 | 2 | 132 |
 | Innovation Forum We drive innovative technology development by connecting innovators, industry, and investors. The Innovation Forum is an international grassroots network that supports scientific entrepreneurs aiming to build ambitious companies at the intersection of science, technology and health. Their IMAGINE IF! initiative is a leading pre-acceleration programme for early-stage science-based ventures providing start-ups with extensive opportunities to take their venture to the next level through structured interactions with key stakeholders, tailored expert mentoring and connections with other founders and companies. Global branches: - UK: Cambridge, Oxford, London, Manchester - US: New York City - Switzerland: Lausanne - Spain: Barcelona - Serbia: Belgrade … Type: | 32 | 4 | 27 | 47 |
 | CEPI (Coalition for Epidemic Preparedness Innovations) We want to stop future epidemics by developing new vaccines for a safer world. CEPI is an innovative partnership between public, private, philanthropic, and civil organisations, launched at Davos in 2017, to develop vaccines against future epidemics. Prior to COVID-19, CEPI’s work focused on developing vaccines against the Ebola Virus Disease, Lassa virus, Middle East Respiratory Syndrome coronavirus, Nipah virus, Rift Valley Fever virus and Chikungunya virus. It has over 20 vaccine candidates against these pathogens in development. CEPI has also invested in new platform technologies for rapid vaccine development against unknown pathogens (Disease X). During the COVID-19 pandemic, CEPI … Type: | 32 | 12 | 17 | 472 |
 | ECOG-ACRIN Cancer Research Group We are a multidisciplinary membership-based scientific organization that designs and conducts biomarker-driven cancer research involving adults who have or are at risk of developing cancer Cancer Clinical Trials, Medical, Surgical & Radiation Oncology, Hematology, Radiology, Nuclear, Internal & Preventive Medicine, Translational Science, Genetics & Molecular Biology, Statistics, Clinical Psychology & Behavioral Science, Epidemiology, and Health Services Type: | 3 | 2 | 2 | 124 |
 |  Amgen Deutschland [Automatic translation follows] Our mission: to help patients. We use biotechnology to treat serious diseases. Amgen was founded in 1980 and is now a leading global independent biotechnology company with around 27,000 employees in almost 100 countries. As a pioneer in biotechnology, we at Amgen have over four decades of experience in the research, development and production of innovative human therapeutics. We focus on diseases for which there are few or no treatment options. Millions of patients with serious illnesses worldwide benefit from our therapies every year. Our medicines are used in nephrology, cardiology, hematology, oncology, bone health and chronic … Type: | 9 | 1 | 6 | 90 |
 | Bulk Pharmaceuticals Task Force An industry trade organization for manufacturers of active pharmaceutical ingredients, intermediates and excipients. The Bulk Pharmaceuticals Task Force (BPTF) is an industry trade organization representing manufacturers of active pharmaceutical ingredients, intermediates and excipients. BPTF addresses regulatory and plant operations issues related to current Good Manufacturing Practices compliance. BPTF establishes sound working relationships with regulators, allied industries and the public and serves as a reliable source for the development and implementation of balanced regulations and industry guidance resources. BPTF undertakes this advocacy on behalf of its member companies to achieve drug product and drug substance supply chain safety for consumers. Type: | 4 | 0 | 4 | 2 |
 | Fundacion Isabel Gemio [Automatic translation follows] The Isabel Gemio Foundation aims to contribute to accelerating research into Muscular Dystrophies, other Neuromuscular Diseases and Rare Diseases, in those biological, pathophysiological, genetic or therapeutic aspects that may affect the development and application of curative treatments for patients, in addition to promoting the exchange of information between experts and with those affected and promoting the development of pharmacology. Research into Muscular Dystrophies, other Neuromuscular Diseases and Rare Diseases Type: | 4 | 1 | 3 | 4 |
 | Avadel Pharmaceuticals PLC Avadel (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. We are disrupting paradigms where it’s needed most – starting with narcolepsy. Our approach includes applying innovative solutions to the development of medications that address the challenges patients face with current treatment options. At Avadel, our core values foster an atmosphere of transformation and collaboration. In everything we do, we consider the patient experience, listening to their needs as we pursue the development and delivery of medicines that will transform the treatment landscape and have the greatest impact on people living with sleep disorders. Learn more … Type: | 3 | 0 | 2 | 204 |
 | Rho Experience, Rho. A global full-service CRO. Changing what it means to work with a global CRO. At Rho, we believe expertise is everything. With team members spanning continents, we bring together the brightest minds in the industry. With a demonstrated track record of success, we guide our clients through the most appropriate program strategies, navigate the unique challenges of clinical trials, and drive development of the high-quality marketing applications demanded by regulatory authorities. Sparked by a shared mission to improve lives, our experts take clients beyond procedural operations and into truly proactive problem-solving. Through a collaborative approach and individualized attention, … Type: | 2 | 0 | 1 | 782 |
 | Don Whitley Scientific Ltd The leading international supplier to the microbiology and tissue culture industries Don Whitley Scientific is a leading international supplier of innovative equipment and services to the microbiology and tissue culture industries. We develop, manufacture, market and service instrumentation and associated products for the public and private sector - primarily for use in hospitals, public health laboratories, food testing organisations and research institutions. We now have the largest, most comprehensive range of workstations specifically designed for the study of anaerobes and microaerophiles. Automated microbiology and cell culture equipment, Contract microbiology laboratory, and Service and maintenance contracts Type: | 2 | 0 | 1 | 55 |
 | GENCOR INNOVATIVE SCIENCE-BASED INGREDIENTS, SUSTAINABLY SOURCED AND DELIVERED THROUGH SUPERIOR TECHNOLOGY! Less aging. More living. We combine a rich 6,000-year history of Ayurvedic wisdom with rigorous science to deliver natural, pure and clinically studied ingredients.* Our commitment to science Our herbal ingredients have been clinically studied and shown effective in both animal and human clinical trials. Many of our clinical trials are peer-reviewed, double-blind controlled trials with impressive results. In addition to formal research tests, our ingredients go through rigorous scientific analysis with our state-of-the-art testing equipment under GLP-certified conditions. Our Ayurvedic roots For 6,000 years, the natural system known as … Type: | 1 | 0 | 0 | 61 |
 | Biocatalysts Ltd Developing #biobasedValue Biocatalysts is a biotechnology company producing speciality enzymes at commercial scales for a variety of industries. Biocatalysts has used its wide range of technical, commercial and regulatory capabilities to develop #BiobasedValue for our customers. Established in 1983, Biocatalysts has been a member of the international BRAIN Group since 2018. Next to first-class research and development services for industry customers to create bio-based products and processes, the Group distributes specialty ingredients, like enzymes or bioactive natural products. Own fermentation and production facilities in Continental Europe, UK and the US, together with the associated biotechnological solution competency complete the value … Type: | 3 | 0 | 3 | 91 |
 | BIOTEM First Class Antibodies & Immunoassays Your partner in immunotechnologies since 1980! Our commitment makes the difference! Expert in immunotechnology, BIOTEM is a contract Research Organisation which complies with ISO 9001:2008 quality standards. Since its establishment in 1980, the company has been the privileged partner of prestigious industrial and academic laboratories for their R&D, diagnostic and therapeutic projects. Based on a high level of expertise and exclusive technologies, BIOTEM implements the most relevant strategies for each project and is pledged to achieve the results outlined in the contract. BIOTEM advantages: - Results guaranteed - An unparalleled traceability throughout your project - Optimal quality of your product … Type: | 17 | 4 | 15 | 42 |
 | ALIOS Conseil - ALIOS recrute!! [Automatic translation follows] ALIOS Conseil is a CRO created in 1995 and specialized in providing experts to the health industries (Pharmaceutical, Medical Device and Cosmetic) Our consulting offer is structured around our 5 departments: Clinical Research, Health Product Vigilance, Medical Affairs, Regulatory Affairs and Quality Assurance. Our objective: meet your needs and support you on your issues ALIOS CONSEIL is: - A tailor-made, fast and efficient response - Motivated, experienced and supported employees throughout their intervention - Transparency for our customers and employees Contact: Website: www.aliosconseil.com Email: aliosconseil@aliosconseil.com Tel. : 07 88 81 64 52 Provision of employees, Management Consulting, … Type: | 1 | 0 | 1 | 4 |
 | Alpha MOS Sensory Analysis Solutions Alpha MOS offers reliable and fast solutions that can control the sensory quality of their products and secure their manufacturing processes. The company specializes in sensory analysis instrumentation and is the worldwide leader of smell, taste and visual industrial analyzers: so-called electronic nose, electronic tongue and electronic eye. It has more than 1000 instruments installed worldwide for Food, Beverage and Packaging industries. First company to market electronic noses, Alpha MOS has always made strong investments in R&D to develop innovative products that would meet the needs not fulfilled that far. Several developments about systems and methods for … Type: | 3 | 1 | 0 | 64 |
 | GenoScreen Genoscreen provides genomic services and innovative solutions in genomics. Created in 2001, GenoScreen is an innovative company specialized in the field of genomics. Using cutting-edge technologies, it analyzes and interprets information encoded in DNA to provide tailored solutions for healthcare, environment, agronomy & agriculture, agri-food, skincare, etc. Unlock the power of DNA: • Services in molecular biology analyses (DNA sequencing, genotyping, detection of gene mutation, metagenomics analysis in complex environment...) • Targeted deep sequencing-based kits for culture-free microbial diagnosis • Expertise and consultancy services for companies which develop projects in genomics GenoScreen also proposes custom-made trainings to people wishing to … | 11 | 6 | 5 | 40 |
 | Laboratoire Traitement du Signal et de l’Image (LTSI) [Automatic translation follows] LTSI research is at the interface of disciplines in the fields of information science and technology and health. Its aims are methodological, technological and clinical and its finalities are interpretation and decision support. It is structured around the core ‘signal-model-image’, these three components providing essential added value. The work is carried out within five teams. Each team is focused on a specific target and is made up of a multidisciplinary group capable of integrating the most recent physiological knowledge in the field into its approach and identifying the underlying methodological issues. The work of the CINETYKS team … Type: | 9 | 1 | 1 | 63 |
 | Département Sciences Biologiques et Médicales [Automatic translation follows] Composed of 11 research units and 1 service unit focused on understanding the fundamental mechanisms of the cell, physiology and pathophysiology, the Biological and Medical Sciences department works to develop innovations that will shape the medicine of tomorrow. cancer, rare diseases, chronic diseases and immunities, microbiology, and cell biology Type: | 3 | 0 | 0 | 1 |
 | SIRIC Montpellier Cancer [Automatic translation follows] A site dedicated to research and innovation in cancerology The National Cancer Institute has established a competitive policy for labeling Integrated Cancer Research Sites (SIRIC). Their objective: - to offer translational cancer research new operational conditions, in order to optimize and accelerate the production of new knowledge; - to promote their dissemination and application in the treatment of cancers. The SIRICs bring together, around the same site, medical services, multidisciplinary research teams (clinical, biological, technological, epidemiological, human, economic and social sciences and public health) and high-tech resources/platforms. Together, these components allow the implementation of integrated and multidisciplinary … Type: | 1 | 0 | 0 | 1 |
 | Biose Industrie Founded in 1951 by pharmacists and microbiologists, biose® has 60-year experience in drug based on live bacteria, giving us a deep understanding of the entire process from discovery to commercialization. Focused on Health through microbiota and microbiome science, we use our skills for the discovery, product development, clinical studies and manufacturing of Live Biotherapeutic Products (LBPs). Our company is drug-GMP certified for the manufacturing of bacteria-based APIs, clinical and commercial products. Microbiome Therapeutics, live biotherapeutics, LBPs, and CDMO Type: | 10 | 5 | 3 | 222 |
 | DBV Technologies On a mission to advance epicutaneous immunotherapy using our innovative technology platform, ViaskinTM DBV Technologies is a global clinical stage biopharmaceutical company founded by pediatricians who believed that food allergies could one day be treated safely and effectively. We are on a mission to advance epicutaneous immunotherapy using our innovative technology platform, ViaskinTM, to develop treatment options for immunologic diseases with significant unmet medical need. This mission drives our commitment to the advancement of treatments for patients and their families. That is why we are investigating a potential new class of immunotherapy, epicutaneous immunotherapy (EPIT), that aims to re-educate the … | 5 | 3 | 0 | 178 |
 | PhysioStim Nonclinical expert in cardiovascular pharmacology & electrophysiology and vascular functions PhysioStim is a French preclinical CRO dedicated to cardiovascular pharmacology and electrophysiology from discovery stages to clinical development. Whatever the therapeutic areas, we ensure robust and valuable preclinical data on cardiac and vascular activities and secondary pharmacology to secure in-vivo development and bring new safe therapies to patients. Thanks to our predictive and translational models, we define the POC of drug discovery, we investigate secondary pharmacology with on and off-target liabilities, and we address the safety purpose to build and support your IND submission (with mandatory and not mandatory assays). … Type: | 1 | 0 | 1 | 10 |
 | Novalix Novalix is a premier drug discovery CRO Novalix is a premier drug discovery partner to biotech firms and pharmaceutical companies. We apply our exceptional scientific talent and exclusive resources across our platforms to improve the odds of success at each critical pre-clinical stage. The better the science, the better the outcomes. For additional information visit www.novalix.com Target based drug discovery, NMR, SPR, Epigenetic targets, Nuclear receptors, Protein-ligand co-crystal structures by XRD, Native mass spectrometry, FBDD, Organic Chemistry, cryo-electron microscopy, Chemical development, Medicinal chemistry, Structural Biology, in vitro pharmacology, DNA-encoded libraries, Flow chemistry, and Chemical process research Type: | 31 | 6 | 27 | 376 |
 | Clean Cells Solution for biologics Clean Cells is a GMP-licensed Contract Development and Manufacturing Organization providing R&D, production and quality control testing services to the biopharmaceutical industry. Our two-part site located in Western France holds an innovative process development platform, BSL2 and BSL3 GMP manufacturing laboratories and analytical areas to develop bespoke assays and perform GMP testing. Clean Cells is part of the Clean Biologics group and benefits from the additional experience of sister company Naobios, a CDMO with considerable experience in the development and manufacture of virus-based products. biosafety testing, Cell Banking and Storage, Viral Clearance, Potency Assay, R&D Contract, Training, … Type: | 9 | 3 | 7 | 123 |
 | PolymerExpert Putting innovation first. Founded in 2000, PolymerExpert is a French company specialized in the field of polymers. Born from a passion for innovation, the company has become a major player in polymer research and development, particularly in the medical sector (implantable & non-implantable medical devices, biotechnologies, pharmaceuticals), the aeronautics, aerospace, defense sector (composite materials, energetic materials, lubrication), industrial sector (building, energy, sports) or the cosmetics sector (smart raw materials, make-up, skincare, solar). PolymerExpert has filed more than 65 patents and devotes 35% of its revenues to the development of new polymers. Today PolymerExpert keeps innovating in this field by mastering … Type: | 9 | 3 | 8 | 19 |
 | GENCLIS SA The Transcription Infidelity Technology GENCLIS SA is a privately-held French Biotechnology that discovered a unique biological mechanism referred as to Transcription Infidelity (TI). Transcription Infidelity is a newly discovered and patented mechanism that incresases RNA-DNA sequence divergences (RDD). TI can lead to base substitutions, insertions and deletions. The latter cause translational frameshifts that have important consequences in determining protein immunogenicity. Genclis currently focuses on defining the effects of TI proteins translated from gapped RNA on normal and pathological humoral immunity. Type: | 0 | 0 | 0 | 6 |
 | Provepharm Act to improve life An independent, international specialty pharmaceutical company, Provepharm leverages the potential of mature and well-known molecules to develop innovative solutions that improve patients' lives. Provepharm develops, manufactures, and markets a range of hospital products including antidotes and dyes. Notably, the company is recognized for its expertise in the endoscopic and surgical dye markets. Working closely with healthcare professionals, Provepharm is committed to developing specific services aimed at helping them enhance clinical practices. With a team of over 160 professionals and offices in France, the US and UK, the company markets its products in over 25 countries worldwide … Type: | 7 | 5 | 2 | 155 |
 | ELITechGroup - A Bruker Company ELITechGroup is a global leader in in-vitro diagnostics, serving hospitals and diagnostic laboratories in over 100 countries. The company develops, manufactures, and markets a comprehensive range of cutting-edge diagnostic products and solutions, including instruments, reagents, and software. To best meet the needs of its customers, ELITechGroup is organized into three specialized business areas, each dedicated to specific IVD technologies and market segments: Molecular Diagnostics (MDx), Biomedical Systems (EBS), and Microbiology (EM). With a global team of about 600 professionals, ELITechGroup is proud to be part of Bruker Corporation. Bruker’s science and technology leadership puts ELITechGroup’s solutions at the forefront of … Type: | 0 | 0 | 0 | 397 |
 | Aureus Pharma Aureus Sciences focuses on providing solutions to the needs of pharmaceutical and biotech companies to leverage information and knowledge as a decision making tool and to increase the speed and efficiency of their drug discovery and development process. Over the course of 10 years and with a significant investment, the Company has developed a unique Knowledge Production Platform which analyzes, indexes and organizes critical chemical and bioactivity information into databases. Using this platform the Company provides best-in-class, scientific databases and associated software applications for use by researcher involved in the drug discovery and development process.The company's range of products includes … Type: | 0 | 0 | 0 | 1 |
 | SYNCROSOME - Cardiovascular Preclinical expert Cardiovascular & respiratory preclinical expertise since 2000 - ETAP-Lab's cardiology branch of services. At a glimpse SYNCROSOME is the cardiology branch of ETAP-Lab, French preclinical CRO dedicated to in vitro & in vivo efficacy studies for pharmaceutical & biotech companies for over 30 years. Range of services SYNCROSOME is dedicated to cardiovascular & respiratory diseases models like HFrEF, HFpEF, acute myocardial ischemia and arterial/pulmonary arterial hypertension... Models in cardiometabolic disorders are also available. Our added value We can accelerate, derisk and support preclinical development of therapeutics thanks to relevant & translatable in vitro and in vivo models. Our experts aim … Type: | 2 | 2 | 1 | 9 |
 | Genoscience Pharma Innovating to Disrupt Cancer Treatment Genoscience Pharma is a French biotech company developing unique small molecules in Oncology. This is the first clinical stage company ever with unique lysosomotropic agents assessed in global clinical trials. For more information, please visit our website, or call us +33 4 91 26 99 50. Liver, Oncology, Clinical Development, Preclinical Development, Discovery, Research & Development, Intellectual Property, Drug Development, and Small Molecule Type: | 6 | 2 | 4 | 4 |
 | BioFeyn BioFeyn is a life sciences company, pioneering advancements in nutrient, medicine, and vaccine delivery to improve food systems and sustainability. Type: | 6 | 0 | 5 | 3 |
 | Cellulis Automation and standardization of cryopreservation processes for Cell Therapies Cellulis (formerly ZF Biotox) provides disruptive cryopreservation technologies in a broad range of biotechnology fields aiming to innovate CELL THERAPY solutions, to streamline BIOPROCESSING production, to enhance BIOBANKING and to improve High Throughput Screening (HTS) campaigns. Frozen Cells in Microplates Ready to Use., Final product formulation for cryopreserved cell therapy, and Cryopreservation of Cell Therapies Type: | 0 | 0 | 0 | 3 |
 | BioSim [Automatic translation follows] Spanish Association of Biosimilar Medicines. BioSim, the Spanish Association of Biosimilar Medicines, is a non-profit organization whose aim is to welcome and represent all pharmaceutical companies established in Spain that develop, produce, market or distribute biosimilar medicines. BioSim opens its doors to laboratories that are already operating in the biosimilar market as well as to companies of original products that have set up, or are going to set up, a biosimilar division; whether for development, production or marketing. This is a new institution, independent of other business associations in the sector, and whose fundamental mission is to … | 12 | 1 | 12 | 20 |
 | Spiderwort Inc. Developing revolutionary biomaterials for regenerative medicine. Spiderwort Inc. is a tissue engineering company specializing in the development of transformative biomaterials for repairing and regenerating tissues within the human body. Type: | 0 | 0 | 0 | 20 |
 | ASW Do you need qualified researchers and scientists in specific areas? Or for longer or shorter periods of time? Do you need to find a solution enabling you to outsource co-workers whom you still want to continue collaborating with? We match staffing solutions so that they correspond to our customers' expectations as regards quality, efficiency, speed, cost and service. When providing staffing services, we identify the most qualified and motivated co-workers and match them to our customers' need. | 1 | 0 | 0 | 144 |
 | 3D Bio-Tissues Applying biology to the creation of 3D structured tissues such as cultivated meat, lab-grown leather, skin and cornea! We are an ambitious start up, aiming to bring functional tissue engineered products to the market. Our unique technology creates tissues with the same nanoscale structural features found in actual living tissue. This allows our tissues to be truly functional and not a random mass of cells and materials. We are taking the lead on creating 100% lab grown meat, that means scaffold free! We are also wholly owned by BSF enterprise which is listed company, in fact we are the only … Type: | 1 | 1 | 0 | 14 |
 | Akari Therapeutics, Plc Developing novel advanced therapies to address unmet needs of patients with autoimmune & inflammatory diseases. Akari Therapeutics, Plc (Nasdaq: AKTX) is a biotechnology company developing advanced therapies for autoimmune and inflammatory diseases. Akari’s lead asset, investigational nomacopan, is a bispecific recombinant inhibitor of complement C5 activation and leukotriene B4 (LTB4) activity. Akari’s pipeline includes a Phase 3 clinical trial program investigating nomacopan for severe pediatric hematopoietic stem cell transplant-related thrombotic microangiopathy (HSCT-TMA). Akari has been granted Orphan Drug, Fast Track and Rare Pediatric Disease designations from the FDA for nomacopan for the treatment of pediatric HSCT-TMA and orphan drug designation … Type: | 0 | 0 | 0 | 14 |
 | Cellply Unravelling immune system function, one cell at a time Cellply is a life-science company focused on developing next-generation analytical tools enabling a deep characterization cancer immunotherapies, cell therapies and cell-based biotherapeutics. Our goal is to support the development of novel cancer immunotherapies by accelerating the R&D, advancing the quality control and monitoring the clinical response to these treatments. Through the use of proprietary microfluidic technologies, highly-automated analytical instruments and AI-powered image and data analytics, the Cellply platform defines the function of the immune system one cell at a time, combining functional data with other multiplex data and providing an unprecedented … Type: | 0 | 0 | 0 | 35 |
 | Acesion Pharma Danish biotech developing novel treatments for Atrial Fibrillation Acesion Pharma is a Danish biotech company founded in 2011. We are aiming to develop more efficacious and safer drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia. The scientific foundation of Acesion Pharma is the novel concept of treating AF by inhibiting the so-called SK channels. These are ion channels present in the heart where they are relevant for regulating the cardiac rhythm. Blocking this ion channel with a selective drug molecule constitutes a novel and promising target for developing improved treatment of AF. Type: | 0 | 0 | 0 | 19 |
 | Sitryx Harnessing the power of cell metabolism to develop groundbreaking disease-modifying therapies Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop first-in-class disease modifying therapeutics in immuno-oncology and immuno-inflammation. The company was co-founded by a team of world-leading scientists from the United States and Europe who have contributed significantly to the field of immunometabolism. Sitryx was founded in 2018 with seed funding from SV Health Investors and raised $30 million Series A funding from an international syndicate of specialist investors including SV Health Investors, Sofinnova Partners, Longwood Fund and GSK. The company has a pipeline of projects at … Type: | 3 | 2 | 3 | 51 |
 | AbolerIS Pharma The Immune system under control Founded by a team with a long cutting-edge translational expertise in regulatory T cells and mechanisms of tolerance, AbolerIS Pharma is developing novel and unique therapeutic approaches to finely regulate the immune system by inducing immune tolerance and preserving useful immune responses in inflammatory, autoimmune, and degenerative diseases. Type: | 5 | 2 | 0 | 16 |
 | Pathios Therapeutics Using human genetics to transform cancer outcomes Pathios Therapeutics are world-leading experts with unique expertise in GPCR drug development, focused on GPR65 as a high-value immunology target with robust genetic links to multiple human diseases. Our clinical-stage oncology programme leverages cutting-edge proprietary genetic insights, transcriptomics, and functional immunology of GPR65 as a key immune cell sensor of acidosis in multiple pathological environments, to bring about a revolutionary new approach to treating a broad spectrum of cancers. We are also building an emerging pipeline in neuroinflammatory and neurodegenerative disorders leveraging the broader immunological roles of this receptor in cell types such … Type: | 2 | 0 | 2 | 20 |
 | Synamics Therapeutics AI-Driven Drug Discovery to Combat Drug Resistance in Cancer - Member of NVIDIA Inception Program At Synamics Therapeutics, our innovative strategy is not just about treating cancer—it's about staying one step ahead. The heart of our approach lies in our advanced AI-driven resistance modeling. This allows us to not only confront existing cancer mutations but also to proactively anticipate and target potential future mutations. By predicting these future resistance pathways, our AI model guides the design of our small molecules to effectively combat evolving cancer threats. This forward-thinking approach ensures the sustained efficacy of our therapies, significantly enhancing patient outcomes … Type: | 4 | 0 | 3 | 8 |
 | TOLREMO therapeutics Stopping non-genetic cancer drug resistance as it emerges TOLREMO therapeutics' mission is to prevent non-genetic cancer drug resistance by dismantling the earliest defense to targeted therapies. Led by phenotypic insights, we discovered a pivotal mechanism that governs critical transcriptional resistance pathways. Our clinical compound TT125-802 is an orally available small molecule inhibitor designed to block these survival techniques to significantly improve the response rates and durability of established treatments. By stopping cancer drug resistance as it emerges, we aim to surmount a universal challenge for current and future targeted therapies for lasting patient benefit. Drug Discovery, Drug Development, Cancer Drug … Type: | 2 | 0 | 2 | 14 |
 | TriptoBIO Access to plant diversity TriptoBIO is developing a platform for producing natural plant compounds that will support the health of our planet. Our goal is to create a future where everyone can benefit from the power of plants, without depleting natural resources. We are applying cutting-edge synthetic biology techniques to produce a class of plant compounds, called diterpenoids, via fermentation. This will enable novel applications of plant diterpenoids and revolutionize a range of industries - while avoiding intensive plant farming and petrochemicals. Our first product will liberate the world from rat poison, by supporting safe rat sex. Type: | 1 | 0 | 1 | 10 |
 | SOLID Therapeutics An early-stage oncology company aiming to treat solid tumors SOLID Therapeutics is an early-stage oncology company spun out of CBMR at the University of Copenhagen. We are developing novel cancer therapeutics with dual mode of action targeting both cancer cells and immune cells to treat solid tumors. Type: | 1 | 0 | 1 | 9 |
 | HHC medical Revolutionizing drug delivery HHC medical is a health tech startup developing a platform technology for targeted and non-invasive drug delivery via wireless electroporation. Drug Delivery, Genetic therapies, and Enabling life-altering therapies Type: | 1 | 0 | 1 | 34 |
 | FimmCyte First disease modifying treatment for Endometriosis. First disease modifying treatment for Endometriosis | 0 | 0 | 0 | 5 |
 | OKYO Pharma OKYO focuses on novel GPCR based therapeutics for eye diseases of unmet need and non-opioid analgesics for chronic pain. OKYO Pharma focuses on: A novel class of membrane-anchored Chemerin receptor GPCR agonist that targets the inflammatory pathways to treat dry eye syndrome, uveitis and allergic conjunctivitis. An agonist for MAS-Related G Protein-Coupled Receptor (MRGPR), a non-opioid analgesic, for ocular and chronic pain management using novel topical and nasal formulations. Type: | 2 | 0 | 0 | 8 |
 | Mikrobiomik rethinking microbiome Mikrobiomik is a bio-pharmaceutical company founded to conduct research into and develop medicines based on the human microbiome. Our vision We aspire to be the first company in the world to market a medicine based on faecal microbiota in the EU. To that end, we are holding talks with both the EMA (European Medicines Agency) and the AEMPS (Spanish Agency for Medicines and Health Products) with a view to establishing protocols on the regulatory requirements for securing an MAA (Marketing Authorization Application) via centralised procedure. Our values Mikrobiomik seeks to lead the paradigm shift entailed by designing therapeutic … Type: | 1 | 0 | 1 | 23 |
 | Bastion Therapeutics Creating a future where inflammatory disorders are curable Bastion Therapeutics is a preclinical stage biotech with a mission to develop novel Treg cell therapies to address the unmet clinical need for inflammatory disorders. We leverage our proprietary GRITTM platform technology to engineer Tregs to modulate the immune system and overcome challenges associated with previous generations of Treg cell therapies. Our vision is to provide life-changing therapies that are efficacious, durable and safe to patients suffering from inflammatory disorders. Type: | 5 | 0 | 5 | 7 |
 | AlveoGene Transforming Rare Respiratory Disease Outcomes Using Inhaled Genes Therapy AlveoGene is an innovative company focused on transforming rare respiratory disease outcomes using inhaled gene therapy. AlveoGene has been created by OSE, Harrington and OCC in partnership with six leading scientists from the world-renowned UK Respiratory Gene Therapy Consortium (GTC). The GTC was founded in 2001 to catalyse the application of pioneering research to gene therapy development and manufacturing related to cystic fibrosis and other respiratory diseases, and originated at Imperial College London and the Universities of Oxford and Edinburgh. AlveoGene has secured an exclusive licence to a proprietary and validated … Type: | 1 | 0 | 1 | 3 |
 | Broken String Biosciences Turning breaks into breakthroughs Broken String Bioscience’s technology platform, INDUCE-seq®, supports the development of cell and gene therapies that are safer by design.INDUCE-seq®, is an NGS-based DNA break mapping platform that enables companies developing cell and gene therapies to measure and quantify the specificity of off-target genetic edits and evaluate the associated genetic outcomes. The platform provides data-driven, actionable insights across the discovery, pre-clinical and clinical development stages to advance gene editing programs. Type: | 2 | 0 | 1 | 42 |
 |  AgriZone Ltd. Zone Group of Comapnies AgriZone is an Afghan company under the commercial name of Zone Group of Companies specialized in curative plants and dry fruits since more than 10 years with the main factory in Kabul and several harvest fields in Mazar-e- Sharif and Kandahar in Afghanistan and in Uzbekistan and Kazakhstan. The company employs nearly 25 workers in low season and 150 workers in high season and has the advantage of selling directly to final clients across the world with no intermediary and keeping the added value where the harvesting and collecting were done. Import and Export, Dry Fruits, … | 0 | 0 | 0 | 2 |
 | GENEIX We personalise prescribing by matching medication to patient data and DNA. Empowering doctors to say 'this drug is not for everyone, but it is for you. Founded in 2012, we are a London based start-up committed to personalising medicine. To achieve this, we've built a strong team with extensive expertise in pharmacogenetics, pharmacology, big data analytics, business strategy, the NHS and creative design. Pharmacogenetics, Personalised Medicine, Bioinformatics, CPOE, Big Data, and Design Type: | 3 | 1 | 1 | 0 |
 | Oxford Brain Diagnostics Ltd Rethinking brain health. Oxford Brain Diagnostics Ltd is rethinking how brain health is assessed and managed. Founded in neuropathological and neuroimaging expertise, the company’s patented Cortical Disarray Measurement (CDM®) technology uses MRI brain scan data to support early and differential diagnosis, track progression, and predict the decline of neurodegenerative diseases. Oxford Brain Diagnostics is committed to assessing brain health based on changes in the cellular structure, supporting drug development, and helping clinicians around the world in their fight to defeat Alzheimer’s and other neurodegenerative diseases. Type: | 0 | 0 | 0 | 18 |
 | Galactica Biotech Galactica Biotech provides a drug repurposing method to identify novel applications for molecules in the market and in development for major and orphan diseases, reducing risk for patients and time and cost for companies. Our Mission With our specialized knowledge we are targeting to set new standards in the pharmaceutical industry adding value to old drugs and contributing to the health of people. Drug Discovery, Molecule characterization, Drug repurposing, and Novel compound applications Type: | 0 | 0 | 0 | 1 |
 | Akamis Bio Harnessing the Power of Tumor Gene Therapy to Turn the Tide in the Battle Against Cancer Akamis is a clinical-stage oncology company whose mission is to leverage its groundbreaking T-SIGn® platform to positively impact the lives of people living with cancer. We are developing a portfolio of solid tumor-targeted T-SIGn® therapeutics which aim to enable a patient’s own immune system to recognize, attack, and clear their cancer. Akamis’ growing pipeline of T-SIGn® therapeutics is anchored by its lead clinical-stage program, NG-350A, which is being investigated in an ongoing Phase 1 clinical study in patients with metastatic or advanced epithelial tumors. … Type: | 5 | 2 | 3 | 49 |
 | Carisma Therapeutics Pioneering CAR Macrophage Immunotherapy to Target Solid Tumors Carisma Therapeutics Inc. is a clinical stage biopharmaceutical company focused on utilizing our proprietary macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. We have created a comprehensive, differentiated proprietary cell therapy platform focused on engineered macrophages and monocytes, cells that play a crucial role in both the innate and adaptive immune response. Carisma is headquartered in Philadelphia, PA. Type: | 4 | 1 | 3 | 83 |
 | Allelica, Inc Empowering the next generation of clinical genomics: Monogenic + Polygenic Allelica is a software and research company democratizing access to clinical-grade Polygenic Risk Score. Allelica is the first Company to have developed a Software as a Service and on-premise infrastructure to allow clinical genetics labs and biopharma companies to perform Polygenic Risk Score analysis in multiple ancestries. Our research work has been published in the American Heart Association Journal, Circulation and presented in the most prestigious conferences in genomics (ASHG) and cardiology (ESC). Our mission is to reduce human suffering making better medicine. We believe in a data-driven primary prevention, … Type: | 5 | 0 | 6 | 13 |
 | ChemAI THE FUTURE OF CHEMISTRY, POWERED BY AI We are a big-data and analysis company focused on enabling reproducibility and predictability in chemistry. With machine learning (ML) and AI powered products, SmartChemistry® empowers the chemist to design, experiment and understand their chemistry on an unprecedented scale. Utilising an advanced knowledge base that combines reaction data, real time sensor data and outcomes, SmartChemistry® enables access to a higher level of experimentation in the chemistry laboratory. Type: | 6 | 1 | 4 | 20 |
SMB